Primary sclerosing cholangitis medical therapy: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{Primary sclerosing cholangitis}} {{CMG}} ==Overview== ==References== {{reflist|2}} {{Gastroenterology}} Category:Autoimmune diseases Category:Gastroenterology [[Ca...")
 
No edit summary
Line 1: Line 1:
{{Primary sclerosing cholangitis}}
{{Primary sclerosing cholangitis}}{{CMG}}
{{CMG}}
==Overview==
==Overview==
 
Standard treatment includes [[ursodiol]], a bile acid naturally produced by the liver, which has been shown to lower elevated liver enzyme numbers in people with PSC, but has not yet been proven effective at prolonging the life of the liver.  Treatment also includes medication to relieve itching ([[antipruritic]]s) and bile acid sequesterants (cholestyramine), [[antibiotic]]s to treat infections, and [[vitamin]] supplements, as people with PSC are often deficient in [[vitamin A]], [[vitamin D]], and [[vitamin K]].
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 22:13, 7 February 2012

Primary sclerosing cholangitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Primary sclerosing cholangitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Primary sclerosing cholangitis medical therapy On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Primary sclerosing cholangitis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Primary sclerosing cholangitis medical therapy

CDC on Primary sclerosing cholangitis medical therapy

Primary sclerosing cholangitis medical therapy in the news

Blogs on Primary sclerosing cholangitis medical therapy

Directions to Hospitals Treating Primary sclerosing cholangitis

Risk calculators and risk factors for Primary sclerosing cholangitis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Standard treatment includes ursodiol, a bile acid naturally produced by the liver, which has been shown to lower elevated liver enzyme numbers in people with PSC, but has not yet been proven effective at prolonging the life of the liver. Treatment also includes medication to relieve itching (antipruritics) and bile acid sequesterants (cholestyramine), antibiotics to treat infections, and vitamin supplements, as people with PSC are often deficient in vitamin A, vitamin D, and vitamin K.

References

Template:Gastroenterology

de:Cholangitis sv:Primär skleroserande kolangit


Template:WikiDoc Sources